Tirzepatide, marketed as Mounjaro, is a newer class of weight loss medication that activates both GLP-1 and GIP receptors, potentially offering even greater weight loss effects
It also notes age eligibility varies by state, with most requiring 18 or older and some restricting to 21 or older, and that some states authorize semaglutide first while requiring step therapy before tirzepatide is approved
The once widely accepted primary role for -amyloid in sporadic AD (known as the amyloid cascade hypothesis) is currently criticised as not being the sole cause of AD, but nevertheless, amyloid accumulation is clearly a part of AD pathology and evokes multifaceted glial responses
And there can be very real negative side effectsnausea, fatigue, dizziness, muscle and hair lossand some people have even reported increased depression and suicidal ideation, although a large-scale meta study seemed to show no direct link to the medication itself
Vitamine C : bienfaits et indications La vitamine C est indispensable au bon fonctionnement de lorganisme et implique dans de nombreux processus
2023 Jan 15;24(2):1703
)
